1. Home
  2. RVYL vs APM Comparison

RVYL vs APM Comparison

Compare RVYL & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryvyl Inc.

RVYL

Ryvyl Inc.

HOLD

Current Price

$5.56

Market Cap

9.3M

ML Signal

HOLD

Logo Aptorum Group Limited

APM

Aptorum Group Limited

HOLD

Current Price

$0.90

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVYL
APM
Founded
2007
2010
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3M
7.5M
IPO Year
2008
2018

Fundamental Metrics

Financial Performance
Metric
RVYL
APM
Price
$5.56
$0.90
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
46.4K
90.8K
Earning Date
05-19-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
60.34
N/A
EPS
N/A
N/A
Revenue
$55,998,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$297.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.65
52 Week High
$8.55
$4.47

Technical Indicators

Market Signals
Indicator
RVYL
APM
Relative Strength Index (RSI) 49.95 48.14
Support Level $5.31 $0.86
Resistance Level $6.15 $1.11
Average True Range (ATR) 0.60 0.14
MACD 0.01 -0.01
Stochastic Oscillator 60.37 22.04

Price Performance

Historical Comparison
RVYL
APM

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Share on Social Networks: